Voleon Capital Management’s Immunovant IMVT Stock Holding History

Voleon Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-39,035	Closed	-$629K	–	903
2025 Q3	$629K	Buy	+39,035	New	+$632K	0.02%	527

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Voleon Capital Management's IMVT Position: Q4 2025 in Review

Voleon Capital Management sold out of Immunovant (IMVT) in Q4 2025, closing a stake of 39,035 shares — an estimated $629K sold.

Voleon Capital Management first reported a position in IMVT in Q3 2025 and held it in 1 quarter. The position peaked at $629K in Q3 2025. 196 funds tracked by Wall St. Rank hold IMVT as of Q4 2025.

Voleon Capital Management reported no remaining Immunovant position as of Q4 2025 after selling out during the quarter.
Voleon Capital Management sold 39,035 Immunovant shares in Q4 2025, an estimated $629K.
Voleon Capital Management first reported a position in Immunovant in Q3 2025 and held it in 1 quarter.
Voleon Capital Management's Immunovant position peaked at $629K in Q3 2025.
196 funds tracked by Wall St. Rank held Immunovant as of Q4 2025.

Based on Voleon Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.